Please wait while we open this resource.
K
Clinical reviews
RISK-BENEFIT ANALYSIS OF PRIMARY PROPHYLAXIS AGAINST PNEUMOCYSTIS JIROVECII PNEUMONIA IN PATIENTS WITH RHEUMATIC DISEASES RECEIVING RITUXIMAB
Seoul National University, University of Alabama at Birmingham
PDF29 pages447 KB
The study evaluates the effectiveness and safety of trimethoprim-sulfamethoxazole (TMP-SMX) as prophylaxis for PJP in patients receiving rituximab, particularly focusing on those also receiving high-dose glucocorticoids. It presents data on adverse events and the incidence of PJP in different patient subgroups, providing insights into the clinical implications of prophylactic treatment in this population.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Repurposing leflunomide and hydroxychloroquine to treat Sjögren's disease (RepurpSS-II): a randomised, double-blind, placebo-controlled, phase 2b trial
Same clinical topic · Rheumatology
EARLY TRAUMA AS THE ORIGIN OF CHRONIC INFLAMMATION: A PSYCHONEUROIMMUNOLOGICAL PERSPECTIVE
Same clinical topic · Rheumatology
IDIOPATHIC INFLAMMATORY MYOPATHIES
Same clinical topic · Rheumatology
MULTIFACTORIAL PATHOGENESIS OF RHEUMATOID ARTHRITIS
Same clinical topic · Rheumatology
SYSTEMIC LUPUS ERYTHEMATOSUS IN CRITICAL CARE: A SYSTEMATIC REVIEW OF ICU OUTCOMES AND MANAGEMENT
Same clinical topic · Rheumatology
RHEUMATOID ARTHRITIS — COMMON ORIGINS, DIVERGENT MECHANISMS
Same clinical topic · Rheumatology
RHEUMATOID ARTHRITIS IN ADULTS
Same clinical topic · Rheumatology
BIOLOGICAL THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS
Same clinical topic · Rheumatology
SYSTEMIC LUPUS ERYTHEMATOSUS: DIAGNOSIS AND TREATMENT
Same clinical topic · Rheumatology